Overview

Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
We want to compare Taxol given weekly with Taxotere given every 3 week both in comination with Xeloda. We are going to compare time to treatment failure and quality of life.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Norwegian Breast Cancer Group
Treatments:
Albumin-Bound Paclitaxel
Capecitabine
Docetaxel
Paclitaxel